BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33655785)

  • 1.
    Luo X; Jiang Y; Chen F; Wei Z; Qiu Y; Xu H; Tian G; Gong W; Yuan Y; Feng H; Zhong L; Ji N; Xu X; Sun C; Li T; Li J; Feng X; Deng P; Zeng X; Zhou M; Zhou Y; Dan H; Jiang L; Chen Q
    J Dent Res; 2021 Jul; 100(8):858-867. PubMed ID: 33655785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
    Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
    J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
    Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
    PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.
    Zhou X; Liu S; Cai G; Kong L; Zhang T; Ren Y; Wu Y; Mei M; Zhang L; Wang X
    Sci Rep; 2015 Nov; 5():15972. PubMed ID: 26522444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ORAOV1 is amplified in oral squamous cell carcinoma.
    Xavier FC; Rodini CO; Paiva KB; Destro MF; Severino P; Moyses RA; ; Tajara EH; Nunes FD
    J Oral Pathol Med; 2012 Jan; 41(1):54-60. PubMed ID: 21623924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ORAOV1-A correlates with poor differentiation in oral cancer.
    Jiang L; Yang HS; Wang Z; Zhou Y; Zhou M; Zeng X; Chen QM
    J Dent Res; 2009 May; 88(5):433-8. PubMed ID: 19493886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Non-Coding RNA NKILA Reduces Oral Squamous Cell Carcinoma Development Through the NF-KappaB Signaling Pathway.
    Hu D; Zhong T; Dai Q
    Technol Cancer Res Treat; 2020; 19():1533033820960747. PubMed ID: 33143574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HOTAIR promotes the invasion and metastasis of oral squamous cell carcinoma through metastasis-associated gene 2.
    Tao D; Zhang Z; Liu X; Zhang Z; Fu Y; Zhang P; Yuan H; Liu L; Cheng J; Jiang H
    Mol Carcinog; 2020 Apr; 59(4):353-364. PubMed ID: 31995261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-Alpha Promotes Invasion and Metastasis via NF-Kappa B Pathway in Oral Squamous Cell Carcinoma.
    Tang D; Tao D; Fang Y; Deng C; Xu Q; Zhou J
    Med Sci Monit Basic Res; 2017 Apr; 23():141-149. PubMed ID: 28386055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral cancer overexpressed 1 (ORAOV1): a regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma.
    Jiang L; Zeng X; Yang H; Wang Z; Shen J; Bai J; Zhang Y; Gao F; Zhou M; Chen Q
    Int J Cancer; 2008 Oct; 123(8):1779-86. PubMed ID: 18688849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition.
    Huang W; Cui X; Chen J; Feng Y; Song E; Li J; Liu Y
    Oncotarget; 2016 Sep; 7(38):62520-62532. PubMed ID: 27613832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
    Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
    Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
    Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
    Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
    Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
    Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
    Chang XS; Zhu J; Yang T; Gao Y
    Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
    Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
    Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-κB-mediated lncRNA AC007271.3 promotes carcinogenesis of oral squamous cell carcinoma by regulating miR-125b-2-3p/Slug.
    Zheng ZN; Huang GZ; Wu QQ; Ye HY; Zeng WS; Lv XZ
    Cell Death Dis; 2020 Dec; 11(12):1055. PubMed ID: 33311454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTA1 promotes the invasion and migration of oral squamous carcinoma by inducing epithelial-mesenchymal transition via the hedgehog signaling pathway.
    Song Q; Wang B; Liu M; Ren Z; Fu Y; Zhang P; Yang M
    Exp Cell Res; 2019 Sep; 382(1):111450. PubMed ID: 31152708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α.
    Cui X; Wang Y; Lan W; Wang S; Cui Y; Zhang X; Lin Z; Piao J
    Cell Oncol (Dordr); 2022 Feb; 45(1):69-84. PubMed ID: 34855159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.